● Overall, the company has poor fundamentals for a medium to long-term investment strategy.
● From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
● Historically, the company has been releasing figures that are above expectations.
Weaknesses
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company does not generate enough profits, which is an alarming weak point.
● The company is in debt and has limited leeway for investment
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 98.49 times its estimated earnings per share for the ongoing year.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
● For the past year, analysts have significantly revised downwards their profit estimates.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● Most analysts recommend that the stock should be sold or reduced.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.